Kyle Bauser

Q: What is Kyle Bauser's success rate?

Kyle Bauser currently has a success rate of 93.01753751145849.

Q: What is the average return of Kyle Bauser's calls?

Their stock ratings have generated an average return of 23.596547787932405.

B. Riley Securities | Healthcare

Kyle Bauser is an analyst from B. Riley Securities specializing in the Healthcare sector. Ranked #1222 out of 4773 analysts, they have issued 15 stock ratings with a success rate of 93.02% and an average return of 23.60%.

With 15 ratings to date, Kyle Bauser is beginning to establish credibility in the Healthcare sector. They have achieved a success rate of 93.02% and an average return of 23.60%, highlighting promising potential as their track record develops further.

#1222

Out of 4773

Total Ratings

+93.02%

Success Rate

+23.60%

Average Return

Recent Ratings Analysis

OBIO

Buy

May 19, 2026

Target

$10.00

Current

$6.12

Performance

53.00%

Kyle Bauser rated OBIO as Buy on May 19, 2026, setting a price target of 10. The call has proven timely, with shares rising 53.00% toward the price target of 10.

ELMD

Buy

May 13, 2026

Target

$40.00

Current

$27.25

Performance

-19.92%

On May 13, 2026, ELMD was given a Buy rating by Kyle Bauser, with a target price of 40. Despite the Buy call, shares fell from 27.25 to 27.25, challenging the optimistic stance.

TCMD

Buy

May 07, 2026

Target

$36.00

Current

$22.40

Performance

-13.88%

TCMD received a Buy rating from Kyle Bauser on May 07, 2026, aiming for 36. The rating hasn’t played out as hoped, with the stock trading 13.88% below expectations.

SNWV

Buy

Mar 30, 2026

Target

$47.00

Current

$4.10

Performance

-76.42%

On Mar 30, 2026, Kyle Bauser published a Buy outlook on SNWV, with a target of 47. Market action contradicted the Buy thesis, as shares slipped to 4.1.

LMAT

Buy

Feb 26, 2026

Target

$117.00

Current

$80.59

Performance

-29.11%

Kyle Bauser on Feb 26, 2026 assigned LMAT a Buy rating, with a price target of 117. The call has struggled to gain traction, with shares losing 29.11%.

INFU

Buy

Feb 25, 2026

Target

$15.00

Current

$12.15

Performance

41.94%

On Feb 25, 2026, Kyle Bauser reaffirmed INFU with a Buy rating, targeting 15. The recommendation was supported by strong follow-through as the stock rose from 12.15 to 12.15.

AURX

Buy

Dec 16, 2025

Target

$3.00

Current

$0.90

Performance

-55.00%

AURX was rated Buy by Kyle Bauser on Dec 16, 2025, with a price objective of 3. This case shows how bullish projections can fail, with the stock now below 0.9.

APYX

Buy

Dec 16, 2025

Target

$6.00

Current

$2.90

Performance

-22.04%

On Dec 16, 2025, Kyle Bauser initiated coverage on APYX with a Buy rating and target of 6. The Buy call has yet to be validated as shares remain 3.10 away from the target.

MBOT

Buy

Dec 03, 2025

Target

$5.50

Current

$1.45

Performance

-41.77%

Kyle Bauser issued a Buy recommendation for MBOT on Dec 03, 2025, price target set at 5.5. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

STXS

Buy

Nov 12, 2025

Target

$4.00

Current

$1.29

Performance

-46.91%

On Nov 12, 2025, STXS was evaluated by Kyle Bauser, who gave a Buy rating and target of 4. Investors saw limited payoff as shares fell short of the 4 target.

VREX

Buy

Aug 08, 2025

Target

$16.00

Current

$18.46

Performance

94.73%

Kyle Bauser rated VREX as Buy on Aug 08, 2025, setting a price target of 16. The call has proven timely, with shares rising 94.73% toward the price target of 16.

TECH

Buy

Jul 09, 2025

Target

$65.00

Current

$72.12

Performance

37.14%

On Jul 09, 2025, TECH was given a Buy rating by Kyle Bauser, with a target price of 65. The stock rallied 37.14% after the rating, narrowing the gap to the target of 65 and validating the bullish stance.

SPOK

Hold

Sep 26, 2024

Target

$15.00

Current

$10.65

Performance

-28.95%

SPOK received a Neutral rating from Kyle Bauser on Sep 26, 2024, aiming for 15. The Hold stance proved prudent, with the market softening by 28.95%.

PFMT

Buy

Jul 25, 2024

Target

$8.00

Current

$3.56

Performance

0.00%

On Jul 25, 2024, Kyle Bauser published a Buy outlook on PFMT, with a target of 8. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 3.56.

Frequency Asked Questions

Who is Kyle Bauser?

Kyle Bauser is an analyst from B. Riley Securities specializing in the Healthcare sector.

What is Kyle Bauser's success rate?

Kyle Bauser currently has a success rate of +93.02%.

How many ratings has Kyle Bauser issued?

Kyle Bauser has issued 15 stock ratings so far.

What is the average return of Kyle Bauser's calls?

Their stock ratings have generated an average return of +23.60%.

What is Kyle Bauser's ranking?

Kyle Bauser is ranked #1222 out of 4773 analysts.

What types of ratings does Kyle Bauser give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Kyle Bauser?

You can follow Kyle Bauser by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Kyle Bauser?

Their latest rating was a Buy on OBIO issued on 2026-05-19.